International Pharmaceutical Supply Chain Security Agreement Act of 2021
Official title: To amend the Bipartisan Congressional Trade Priorities and Accountability Act of 2015 to include principal negotiating objectives of the United States relating… Show full official titleShow less
Official title: To amend the Bipartisan Congressional Trade Priorities and Accountability Act of 2015 to include principal negotiating objectives of the United States relating to trade in pharmaceutical products, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Trade.
International Pharmaceutical Supply Chain Security Agreement Act of 2021
This bill establishes principal trade negotiating objectives of the United States with respect to pharmaceutical products, including objectives regarding subsidies and government procurement. It also extends through July 1, 2023 (or July 1, 2026, if the President receives an extension) the authority of the President to enter into trade agreements with foreign countries.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4711: International Pharmaceutical Supply Chain Security Agreement Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-4711/
"H.R. 4711: International Pharmaceutical Supply Chain Security Agreement Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-4711/.
H.R. 4711, 117th Cong. (2026), https://openamerica.io/bill/117-HR-4711/.
[H.R. 4711: International Pharmaceutical Supply Chain Security Agreement Act of 2021](https://openamerica.io/bill/117-HR-4711/)